Axsome Therapeutics, Inc. (AXSM) research
Axsome Therapeutics, Inc.- Sector
- Pharmaceuticals
- Last price
- $207.78
- As of
Axsome Therapeutics, Inc. (AXSM): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-10.
As of . Source: SEC EDGAR filings for AXSM. Method and limitations.
Share the AXSM intelligence card
See AXSM live in the terminal
Track AXSM's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live AXSM terminal, freeActive signals for AXSM
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 14.9%, EPS $-0.99 vs $-0.8616 estimate
- highCONSENSUS_BUY
9 tracked funds increased AXSM this 2026Q2, institutional consensus
- highCONSENSUS_BUY
4 tracked funds increased AXSM this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 93% of AXSM (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 92% of AXSM (2026Q2)
FREE, NO ACCOUNT
Every signal on AXSM, as it fires
You are seeing 5 of 57 signals recorded on AXSM since 2026-05-16.
The five above landed across 3 days. The other 52 were recorded on 3 other days. 47 of the 57 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AXSM (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 05464T104 · 2026Q2 | $163.9M | 0.12% | , |
| D. E. Shaw & Co., Inc.CUSIP 05464T104 · 2026Q2 | $148M | 0.07% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 05464T104 · 2026Q2 | $136.1M | 0.05% | , |
| Point72 Asset Management, L.P.CUSIP 05464T104 · 2026Q2 | $102M | 0.11% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 05464T104 · 2026Q2 | $64.1M | 0.09% | , |
| CITADEL ADVISORS LLCCUSIP 05464T104 · 2026Q2 | $62.6M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 05464T104 · 2026Q2 | $14.2M | 0.06% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AXSM
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more AXSM signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to AXSMand get the insider, 13F, options, and confluence read in one view.